Qiagen NV QIA-DE:XETRA

*Data is delayed | EUR
Last | 5:38 PM CEST
42.40quote price arrow down-1.62 (-3.68%)
Volume
579,413
52 week range
37.95 - 51.56
Loading...
  • Open43.39
  • Day High43.71
  • Day Low42.40
  • Prev Close44.02
  • 52 Week High51.56
  • 52 Week High Date11/26/21
  • 52 Week Low37.95
  • 52 Week Low Date03/08/22

Key Stats

  • Market Cap10,492.5M
  • Shares Out227.45M
  • 10 Day Average Volume491,306.73
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.45

KEY STATS

  • Open43.39
  • Day High43.71
  • Day Low42.40
  • Prev Close44.02
  • 52 Week High51.56
  • 52 Week High Date11/26/21
  • 52 Week Low37.95
  • 52 Week Low Date03/08/22
  • Market Cap10,492.5M
  • Shares Out227.45M
  • 10 Day Average Volume491,306.73
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.45

RATIOS/PROFITABILITY

  • EPS (TTM)2.10
  • P/E (TTM)20.19
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date01/25/2017
  • Div Amount1.08
  • Split Date-
  • Split Factor-

Latest On Qiagen NV

There is no recent news for this security.

Profile

MORE
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other...
Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Address
Hulsterweg 82
Venlo
5912 PL
Netherlands